Transvenous adrenalectomy for advanced carcinoma of the breast

Since in our extensive series, there was only minimal morbidity and no mortality, we suggest that transvenous adrenalectomy be recommended to more patients with advanced carcinoma of the breast. In this way, patients would be spared an additional operative procedure, while treatment efficacy is monitored by available tests of adrenal function. Since the success rate approaches that offered by surgical ablation, this simpler and less time-consuming approach to adrenalectomy may result in the modality being offered to selected candidates who would otherwise not consider the alternative of surgical adrenal ablation.